La Opinión de Zamora gives extensive coverage to the new incorporation of Angel Nebreda to the IRB Barcelona Oncology Programme. The “Signalling and Cell Cycle” group that he directs will focus its research on the p38 MAPK protein, which inhibits tumour initiation, and the RINGO/Speedy group of proteins which regulate the cell cycle. “We are very interested in studying aspects of the breast and colon cancers, and also in studying metastasis, wich links with the interests of the Institute and its group of experts, such as Eduard Batlle, Roger Gomis, Travis Stracker and Joan Massagué himself”, Nebreda said.

• Read the news (PDF in Spanish)
• La Opinión de Zamora